Briefly, PSMA in tumor capillaries was expressed in 19% follicular adenomas (FA), 46% follicular carcinomas (FTC), 51% papillary carcinomas (PTC), and 40–50% high-grade thyroid cancers. This evidence concerns the gene FOLH1 and thyroid gland papillary carcinoma.